E. Lawrence Hill

Nessuna posizione attualmente

73 anni

Health Technology

Consumer Services

Profilo

E.
Lawrence Hill, Jr. has been Acting Chief Operating Officer and President since joining Trimeris, Inc. in March 2007.
He is President and a Founding Principal of Hickey & Hill, which was founded in 1984.
In 2006, Mr. Hill served as Chief Executive Officer of Border Foods, Inc. From 2003 to 2005, he was Chief Executive Officer of Deltagen, Inc. For five years, he has been involved in management advisory assignments with iLogistix, Centerpoint Broadband Technologies and Signature Fruit LLC, where he served as Interim Chief Executive Officer.
Mr. Hill is a graduate of Stanford University, where he received a BS in Electrical Engineering and an MS in Industrial Engineering.

Precedenti posizioni note di E. Lawrence Hill

Società	Posizione	Fine
Trimeris, Inc. Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.	President	02/01/2008

Vedi nel dettaglio l'esperienza di E. Lawrence Hill

Formazione di E. Lawrence Hill

Stanford University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di E. Lawrence Hill

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Trimeris, Inc. Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.	Health Technology